GCTKGlucotrack, Inc.vs its industry peers
A metric-by-metric comparison of Glucotrack, Inc. against Surgical & Medical Instruments & Apparatus — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GCTKEsta | $25M#8 | — | — | 121.6x#11 | 378.3%#2 | 14.1%#6 | -7735.6%#11 | — | — | — | -97.9%#14 | — |
| PETV | $39M#1 | — | 28.5x#12 | 33.9x#10 | 0.8%#8 | -24.7%#12 | -793.9%#9 | -772.3%#12 | -647.5%#8 | — | -4.7%#3 | — |
| NSPR | $36M#2 | — | 1.1x#5 | 4.0x#7 | 28.1%#6 | -52.4%#13 | -552.6%#7 | -154.8%#7 | -246.3%#6 | 4#4 | -68.2%#8 | — |
| SNWV | $36M#3 | 5.1x#4 | 12.8x#11 | 0.8x#4 | 35.0%#5 | 135.7%#1 | 11.2%#1 | 423.9%#1 | 12.2%#1 | 6#1 | -88.2%#13 | — |
| MCAGU | $34M#4 | — | — | — | — | -15.1%#10 | — | — | — | — | 19.6%#1 | — |
| PAVM | $32M#5 | — | 0.9x#4 | 451.6x#12 | -97.6%#12 | -111.8%#15 | -30712.7%#12 | -10.8%#2 | — | — | -67.0%#7 | — |
| MCAG | $32M#6 | — | — | — | — | -15.1%#10 | — | — | — | — | 2.4%#2 | — |
| ARAY | $28M#7 | — | 0.7x#2 | 0.1x#1 | -12.3%#10 | -2992.0%#16 | -6.6%#2 | -118.0%#5 | -16.5%#2 | 1#7 | -86.4%#12 | — |
| BEAT | $24M#9 | — | 2.9x#7 | — | — | -8.1%#9 | — | -257.0%#8 | — | — | -70.4%#9 | — |
| FEMY | $21M#10 | 0.4x#3 | 5.3x#10 | 9.3x#8 | 40.8%#4 | 1.0%#7 | -767.0%#8 | -462.1%#11 | — | — | — | — |
| RVP | $21M#11 | — | 0.3x#1 | 0.6x#2 | 15.8%#7 | -5.7%#8 | -55.3%#5 | -17.2%#3 | -29.7%#3 | 5#2 | -13.3%#4 | — |
| CNSY | $16M#12 | 0.2x#1 | 2.8x#6 | 3.0x#6 | -10.5%#9 | -72.5%#14 | -293.5%#6 | -409.8%#10 | -146.1%#4 | 4#4 | -80.8%#11 | — |
| ICU | $15M#13 | — | 3.6x#9 | 12.5x#9 | 814.1%#1 | 51.1%#3 | -986.6%#10 | -282.8%#9 | -252.7%#7 | 5#2 | -61.1%#6 | — |
| AEMD | $4M#16 | 0.2x#2 | 0.8x#3 | — | -100.0%#13 | 46.6%#5 | — | -137.5%#6 | — | — | -98.4%#15 | — |
| MDAIW | $14M#14 | — | — | 0.7x#3 | -33.6%#11 | 50.1%#4 | -43.8%#3 | — | — | 3#6 | -18.2%#5 | — |
| NMTC | $13M#15 | — | 3.3x#8 | 1.4x#5 | 163.5%#3 | 70.7%#2 | -46.5%#4 | -95.7%#4 | -229.5%#5 | — | -74.3%#10 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 3841). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Table built 2026-09-18.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice